An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

This health crisis is largely attributed to sedentary lifestyles, excessive consumption of processed and fast food, and ...

Phase 3 trials of injectable semaglutide have shown it has ... the drug could eventually be approved as a treatment for the fatty liver disease NASH, and as an obesity treatment.

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced st ...

TUCSON, AZ / ACCESS Newswire / June 2, 2025 / Umbrella Labs , a leading supplier of advanced research chemicals, announced the expansion of its peptide catalog to include Retatrutide (LY3437943), an ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

In recent years, a certain type of medication has seen increased popularity due to its purported health effects. But taking ...

Ozempic may affect your face, bowel movements and hair. Check out the Ozempic side effects before taking this anti-diabetes ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

Apr. 30, 2025 — Semaglutide effectively treats liver disease in two thirds of patients, new research has ... New Human 'Multi-Zonal' Liver Organoids Improve Injury Survival in Rodents Apr. 16 ...